Upcoming conferences

March 28, 2025

Our CEO, Pierre Vandepapelière, will be attending BioVaria on April 28th in Munich.

Pitch Monday 28th April 11:30 AM

Our CEO, Pierre Vandepapelière, will be attending LSX World Congress on April 29-30 In London.

Showcase Tuesday 29th April 12:00-12:15

Our CEO, Pierre Vandepapelière, will be attending the Swiss Biotech Day on May 5-6 in Basel.

Presentation slot TBC

Our CEO, Pierre Vandepapelière, and our CSO, Damien Toulorge, will be attending Bio€quity on May 12-14 in Bruges.

Presentation slot TBC

Our CEO, Pierre Vandepapelière, will be attending LSX Nordic Congress on May 20-21 in Bergen.

Showcase Tuesday 20th May 02:40 PM – Room Kongesalen 5

Our CSO, Damien Toulorge, will be attending Bio International Convention on June 16-19 in Boston .

Presentation slot TBC

Our CEO, Pierre Vandepapelière, will be attending the Healthtech Accelerations Summit on June 26th in Paris.

Some of our team members will be attending the New Horizons in Neurodegeneration conference on October 9-10 in Leuven.

About Merieux Equity Partners

Mérieux Equity Partners (MxEP) is an AMF-accredited management company dedicated to equity investments in healthcare. MxEP actively supports entrepreneurs and companies with differentiated products and services, giving them privileged access to its sector expertise and international network. MxEP currently manages c.€1.5bn ($1.6bn) AUM.

www.merieux-partners.com

About Noshaq Partners

Noshaq is a Belgian investment fund and project developer with a portfolio of 477 companies. Noshaq is the reference financial partner for the creation and development of SMEs in the Liege region (Wallonia). Over the years, it has developed a range of financing vehicles in line with the needs and trends of the market and its strategy. Each service offered by Noshaq (capital – loan – leasing) is always determined according to the demands and needs of the owner-investor. Its objective is always to have a leverage effect on the company’s development.

www.noshaq.be

About Sambrinvest

With over 35 years of experience working alongside companies and entrepreneurs, more than 280 portfolio companies and 170 million euros in assets under management, Sambrinvest is a major venture capital player in Wallonia. More than an investment fund, Sambrinvest is also a catalyst for the development of local ecosystems, such as biotech, digital and engineering.

www.sambrinvest.be